LOGIN  |  REGISTER

Veeva Systems to Release Fiscal 2024 Third Quarter Results on December 6, 2023

November 15, 2023 | Last Trade: US$233.26 3.81 -1.61

PLEASANTON, Calif., Nov. 15, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter, which ended October 31, 2023, after market close on December 6, 2023. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results.

Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event.

Event:     

Veeva's Fiscal 2024 Third Quarter Results Conference Call

Date:         

Wednesday, December 6, 2023

Time:       

2:00 p.m. PT (5:00 p.m. ET)

Conference Call Registration: https://conferencingportals.com/event/badXudFz

Webcast:   

ir.veeva.com

About Veeva Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts.

Investor Relations Contact:

  

Gunnar Hansen

Veeva Systems Inc.

267-460-5839

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Media Contact:

Maria Scurry
Veeva Systems Inc.
781-366-7617
This email address is being protected from spambots. You need JavaScript enabled to view it.

  
Astria Therapeutics

Stock Quote

Last Trade: US$233.26
Daily Change: -3.81 -1.61
Daily Volume: 850,948
Market Cap: US$37.870B

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page